Brief: Sensorion Expects It Can Finance Operations Until End Q2 2025

Sensorion SA

14/03/2024 06:50

March 14 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION REPORTS FULL-YEAR 2023 FINANCIAL RESULTS AND
BUSINESS
UPDATE
    * EXPECTS IT WILL BE ABLE TO FINANCE ITS OPERATIONS UP UNTIL
END
OF Q2 2025.
    * AS OF DECEMBER 31, 2023, THE COMPANY HAD €37.0 MILLION IN
CASH
AND CASH EQUIVALENTS
    * ON TRACK TO SUBMIT CLINICAL TRIAL APPLICATIONS FOR ITS
SECOND
GENE THERAPY, GJB2-GT, IN H1 2025
    * NET LOSS WAS -€22.1 MILLION FOR 2023, COMPARED TO -€23.2
MILLION
FOR 2022
    * FINAL DATA READOUT IS EXPECTED IN Q3 2024 FOR ITS TRIAL OF
SENS-401 IN PREVENTION OF RESIDUAL HEARING LOSS
    * FY OPERATING LOSS EUR 22.3 MILLION VERSUS LOSS EUR 23.1
MILLION
YEAR AGO

Source text for Eikon:  urn:newsml:reuters.com:*:nBw3P6qXQa
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))